Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, Florida, USA.
Division of Gastroenterology & Hepatology, University Medical Center Hamburg - Eppendorf, Hamburg, Germany.
Dig Endosc. 2021 Jul;33(5):822-828. doi: 10.1111/den.13856. Epub 2020 Nov 17.
While single-use and detachable-tip duodenoscopes have been recently developed to overcome risks of infection transmission, there are no reliable tools to objectively assess their technical performance. We evaluated the reliability and validity of a newly developed tool to assess the technical performance of reusable duodenoscopes.
An assessment tool was developed to measure duodenoscope performance based on three distinct criteria: maneuverability, mechanical/imaging characteristics and ability to perform requisite interventions. The assessment tool was tested prospectively on duodenoscopes used in endoscopic retrograde cholangiopancreatography (ERCP) procedures at nine academic medical centers over a 6-month period. The main outcome was reliability of the duodenoscope assessment tool, which was estimated using Cronbach's coefficient alpha (α). The secondary outcome was validity of the assessment tool.
The assessment tool evaluated technical performance of reusable duodenoscopes in 1080 ERCP procedures. Indications were biliary in 92.8% and pancreatic in 7.2% procedures. The overall Cronbach's coefficient α for maneuverability was 0.81, assessment of mechanical/imaging characteristics was 0.92, and ability to perform requisite interventions was 0.87. On multiple linear regression analysis, prolonged procedure duration, older patient age and pancreatic interventions were significantly positively associated with higher (worse) scores.
The newly developed assessment tool appears reliable and valid for evaluating the technical performance of duodenoscopes. Registration: ClinicalTrials.gov Identifier: NCT04004533.
虽然最近已经开发出了一次性使用和可分离式尖端十二指肠镜来克服感染传播的风险,但仍缺乏可靠的工具来客观评估其技术性能。我们评估了一种新开发的工具,用于评估可重复使用十二指肠镜技术性能的可靠性和有效性。
根据三个不同的标准(可操作性、机械/成像特性和进行必要干预的能力)开发了一种评估工具来测量十二指肠镜的性能。该评估工具在 9 个学术医疗中心进行内镜逆行胰胆管造影(ERCP)手术的 6 个月期间,前瞻性地对十二指肠镜进行了测试。主要结果是十二指肠镜评估工具的可靠性,使用 Cronbach's 系数 alpha(α)进行评估。次要结果是评估工具的有效性。
该评估工具评估了 1080 例 ERCP 手术中的可重复使用十二指肠镜的技术性能。适应证在 92.8%的胆道手术和 7.2%的胰腺手术中。可操作性的总体 Cronbach's 系数α为 0.81,机械/成像特性的评估为 0.92,进行必要干预的能力为 0.87。在多元线性回归分析中,手术时间延长、患者年龄较大和胰腺干预与较高(较差)评分呈显著正相关。
新开发的评估工具似乎可靠且有效,可用于评估十二指肠镜的技术性能。注册:ClinicalTrials.gov 标识符:NCT04004533。